Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, single-dose, two-sequence, two-period crossover study to
investigate the pharmacokinetics between a tablet containing 75 mg of Clopidogrel and 100 mg
of Aspirin and the simultaneous administration of the separate formulations of the two drugs
in healthy male volunteers.